| Bicara Therapeutics Inc. |
Other* |
Common Stock |
1,013,853 |
$13,426,861 |
$13.24 |
16 Sep 2024 |
Eight Roads Ventures India Healthcare IV, L.P. |
| Xilio Therapeutics, Inc. |
Other* |
Common Stock |
218,705 |
$181,525 |
$0.8300 |
26 Oct 2021 |
Eight Roads Investments |
| Structure Therapeutics Inc. |
Other* |
Ordinary Shares |
5,266,286 |
|
|
07 Feb 2023 |
Eight Roads Investments |
| Structure Therapeutics Inc. |
Other* |
Ordinary Shares |
624,239 |
|
|
07 Feb 2023 |
ERVC Healthcare IV, LP |
| Structure Therapeutics Inc. |
Other* |
Ordinary Shares |
494,035 |
|
|
07 Feb 2023 |
ERVC Healthcare V, LP |
| Structure Therapeutics Inc. |
Other* |
Ordinary Shares |
89,201 |
|
|
07 Feb 2023 |
ERVC Healthcare Advisors IV, LP |
| Bicara Therapeutics Inc. |
Other* |
Series B Preferred Stock |
0 |
|
|
16 Sep 2024 |
Eight Roads Ventures India Healthcare IV, L.P. |
| Bicara Therapeutics Inc. |
Other* |
Series C Preferred Stock |
0 |
|
|
16 Sep 2024 |
Eight Roads Ventures India Healthcare IV, L.P. |
| Bicara Therapeutics Inc. |
Other* |
Series Seed Preferred Stock |
0 |
|
|
16 Sep 2024 |
Eight Roads Ventures India Healthcare IV, L.P. |
| Structure Therapeutics Inc. |
Other* |
Series A+ Convertible Preferred Shares |
0 |
|
|
07 Feb 2023 |
Eight Roads Investments |
| Structure Therapeutics Inc. |
Other* |
Series A+ Convertible Preferred Shares |
0 |
|
|
07 Feb 2023 |
ERVC Healthcare Advisors IV, LP |
| Structure Therapeutics Inc. |
Other* |
Series A Convertible Preferred Shares |
0 |
|
|
07 Feb 2023 |
ERVC Healthcare IV, LP |
| Structure Therapeutics Inc. |
Other* |
Series B-1 Convertible Preferred Shares |
0 |
|
|
07 Feb 2023 |
Eight Roads Investments |
| Structure Therapeutics Inc. |
Other* |
Series B-1 Convertible Preferred Shares |
0 |
|
|
07 Feb 2023 |
ERVC Healthcare V, LP |
| Structure Therapeutics Inc. |
Other* |
Series B Convertible Preferred Shares |
0 |
|
|
07 Feb 2023 |
Eight Roads Investments |
| Structure Therapeutics Inc. |
Other* |
Series B Convertible Preferred Shares |
0 |
|
|
07 Feb 2023 |
ERVC Healthcare Advisors IV, LP |
| Xilio Therapeutics, Inc. |
Other* |
Series B Preferred Stock |
0 |
|
|
26 Oct 2021 |
Eight Roads Investments |